comparemela.com

Latest Breaking News On - Ikena oncology - Page 10 : comparemela.com

Foundery, a new biotech venture firm, sets out to speed early immune drug research

BioPharma

United statesSan franciscoPionyr immunotherapeuticsMichel streuliBiocapital srini akkarajuJeff brodyMax krummelImmunox initiativeUniversity of californiaGilead sciencesUniversity of arizonaMerck coDive briefIkena oncologyCure venturesSamsara biocapital

Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028

/PRNewswire/ DelveInsight s Medical Second Opinion Market Insights report provides the current and forecast market analysis, individual leading medical.

United statesCity ofUnited kingdomPrnewswire delveinsightExpressi ontherapeuticsKlus pharmaAstellas pharmaTaizhou hanzhongTakara bioShruti thakurInnocare pharmaEmtora biosciencesTransthera biosciencesAthira pharmaBristol myers squibbInmune bio

DelveInsight Business Research, LLP: Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028

DelveInsight Business Research, LLP: Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomAthira pharmaExpressi ontherapeuticsEli lillyTransthera biosciencesPrnewswire delveinsightTaizhou hanzhongInmune bioKlus pharmaBristol myers squibbEmtora biosciencesAstellas pharmaShruti thakurOcellaris pharma

Ikena Oncology, Inc (NASDAQ:IKNA) Sees Significant Increase in Short Interest

Ikena Oncology, Inc. (NASDAQ:IKNA – Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 793,000 shares, a growth of 10.1% from the July 15th total of 720,400 shares. Currently, 3.1% of the shares of the company are […]

United statesDimensional fund advisorsIkena oncology incVirtu financialMetlife investment managementAmerican international group incMillennium managementIkena oncologyGet free reportInternational groupFund advisorsIkena oncology dailyNasdaq ikna

Ikena Oncology, Inc (NASDAQ:IKNA) Short Interest Update

Ikena Oncology, Inc. (NASDAQ:IKNA – Get Free Report) saw a significant increase in short interest in July. As of July 31st, there was short interest totalling 793,000 shares, an increase of 10.1% from the July 15th total of 720,400 shares. Based on an average daily trading volume, of 114,200 shares, the short-interest ratio is presently […]

United statesIkena oncology company profileDimensional fund advisorsIkena oncology incVirtu financialMirae asset global investments coMillennium managementMetlife investment managementIkena oncologyGet free reportFund advisorsAsset global investmentsLife investment managementIkena oncology dailyNasdaq ikna

vimarsana © 2020. All Rights Reserved.